Nalanda Capital trimmed its stake in Advanced Enzyme Technologies from 8.45% to 8.38%, selling 1,48,500 shares.
A manufacturer of industrial enzymes, Advanced Enzyme Technologies produces biocatalysts for applications across pharmaceuticals, food processing, textiles, biofuels, and animal nutrition. The company develops customized enzyme solutions that enable efficient biochemical processes for its diverse global customer base. Its focus on specialized enzyme formulations, technical expertise, and application-specific support distinguishes it in the competitive industrial biotechnology sector.
Singapore-based investment firm founded in 2007 by Pulak Prasad, formerly co-head of Warburg Pincus in India. It invests only in listed Indian companies, taking large, long-held stakes in a small number of high-quality mid and small caps and rarely selling. It manages about US$5 billion, mainly for US endowments, foundations and family offices, and holds stakes of up to about 10% in companies like Cera Sanitaryware, AIA Engineering, Amara Raja, Page Industries and Jyothy Labs.
